NCT07031661

Brief Summary

Bipolar disorder (BD) is a serious, complicated, familial aggregation onset of mental illness, which has the characteristics of five-low and one-high, namely high prevalence, high recurrence rate, high morbidity and mortality, high comorbidity rate and younger age characteristics. This situation will seriously influence one's behaviour or thinking, cognitive, emotional, social and occupational function, causing the heavy burden of disease. But, early recognition and early diagnosis are difficult to achieve at present. Based on the preliminary research results of the project team, it is found that BD can be identified early through specific dimensions, and early recognition is crucial for the prognosis of patients. The earlier the intervention for BD is implemented, the better the prognosis, especially the functional prognosis, but the difficulty lies in how to implement it. Establishing a high-quality clinical cohort of BD high-risk population is a necessary prerequisite. This study intends to establish a high-quality, large-sample cohort through multi-center, long-term and prospective cohort design and enroll 100 BD high-risk patients every year, a total of 400 cases in 4 years. The electronic mental health service platform will be used for ten years of intensive follow-up. Multi-modal data including clinical characteristics, genetic, cognitive, neuroimaging, sleep monitoring, eeg, eye movement, speech, facial expression and movement were collected to construct the database. On this basis, the interaction of biological factors, clinical risk factors, and environmental risk factors in the onset of BD is discussed to establish a big data prediction model for BD onset in high-risk populations. The effective subgroups of early intervention were analyzed and screened. An ethical and individualized prediction model of the effectiveness and safety of early intervention for the BD high-risk population was constructed. It is hoped that the smooth implementation of this project can provide empirical evidence for the early identification, prevention and intervention of BD. To provide clinicians with real data-driven decision-making guidance to assist in selecting personalized and precise treatment; Ultimately promote the prognosis and functional recovery of BD patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 17, 2024

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 22, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

June 22, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

October 17, 2024

Last Update Submit

June 12, 2025

Conditions

Keywords

bipolar disorderhigh-riskoffspringatypical depressioncohort studyprediction model

Outcome Measures

Primary Outcomes (3)

  • The prevelence of mental illnesses over time in all three groups.

    The K-SADS-PL or SCID will be used to screen the mental illnesses of all three group. The cumulative prevelence of all follow-up points will be calculated.

    4 year, participants will be followed-up every one year.

  • The differences of developmental trajectory of brain structure and function between three groups.

    All participants will complete the brain MRI scan every each year, which including structural MRI, resting-state and task functional MRI. The volume, thickness, Reho, attributes of structural and functional brain networks will be calculated and compared longitudinally.

    4 year, participants will be scaned every each year.

  • The differences of developmental trajectory of multi-model features between three groups.

    The electroencephalogram (EEGs), eye movement, Polysomnography (PSG), voice, expression and gait movement will be recorded at baseline and annual follow-up period. The features of event-related potentials like N1 and P3, event-related spectral perturbation will be extracted from EEG. Saccadic latency, saccadic peak velocity, saccadic amplitude, saccade count, average fixation duration, total fixation duration, visit count, velocity gain, position gain of smooth tracking, accuracy and latency of visual search will be extracted from eye movement records. Total sleep time, sleep efficiency, sleep onset latency, rapid eye movement (REM) sleep latency, awakenings number, wake after sleep onset, number of microarousals, apnea-hypopnea index, time of REM sleep will be analyzed according to PSG. Formant frequency, intensity, bandwidth, Hammarberg Index, Mel-frequency cepstral coefficients (MFCC) will be acquired from voice data. The facial expression entropy and facial action units will be ca

    4 year, participants will be followed-up every one year.

Secondary Outcomes (4)

  • The differences of developmental trajectory of cognitive function between three groups.

    4 year, participants will be followed-up every one year.

  • The differences of quality of sleep between three groups.

    4 year, participants will be followed-up every one year.

  • The differences of quality of life between three groups.

    4 year, participants will be followed-up every one year.

  • The differences of genetic phenotypes and between three groups.

    4 year, participants will be followed-up every one year.

Study Arms (3)

high-risk offsprings of patients with bipolar disorder (HR-BD)

the 6-18 years old health offsprings with at least one parent with bipolar disorder

Other: This was an observational study with no intervention.

patients with atypical depression

the 6-18 years old patients with atypical depression according to the criteria of DSM-5

Other: This was an observational study with no intervention.

health control

health juveniles with age and gender matched with HR-BD

Other: This was an observational study with no intervention.

Interventions

This was an observational study with no intervention.

health controlhigh-risk offsprings of patients with bipolar disorder (HR-BD)patients with atypical depression

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

1. High-risk offsprings of parents with BD: health offsprings of patients with bipolar disorder; 2. Atypical depression: patients with atypical depression according to DSM-5; 3. Health control: Health individuals with age and gender matched with high-risk offsprings.

You may qualify if:

  • High-risk offsprings of parents with BD: Aged 6-18 yrs, both male and female. Offsprings and parents can sign the writtened informed consent form. At least one of parents was diagnosed with bipolar disorder by two or more senior psychiatric doctor.
  • Atypical depression: Aged 6-18 yrs, both male and female. Patients and parents can sign the writtened informed consent form. Patients was diagnosed with atypical depression by two or more senior psychiatric doctor according to DSM-5. The disease phase and treatment regime are unrestricted.
  • Health control: health individuals with age and gender matched with high-risk offsprings, no psychiatric family history.

You may not qualify if:

  • High-risk offsprings of parents with BD: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.
  • Atypical depression: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. Patients cormobid substance abuse or treated with MECT in recent half a year.
  • Health control: Individuals with psychiatric family history, severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

10ml blood sample

MeSH Terms

Conditions

Bipolar Disorder

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2024

First Posted

June 22, 2025

Study Start

October 15, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

June 22, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations